Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases.

[1]  Mark M. Davis,et al.  Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients , 2021, Science Translational Medicine.

[2]  C. Mathews,et al.  Human islet T cells are highly reactive to preproinsulin in type 1 diabetes , 2021, Proceedings of the National Academy of Sciences.

[3]  S. Chung,et al.  Approaches to Establishing Tolerance in Immune Mediated Diseases , 2021, Frontiers in Immunology.

[4]  G. Blanchard-Rohner.  Vaccination in Children With Autoimmune Disorders and Treated With Various Immunosuppressive Regimens: A Comprehensive Review and Practical Guide , 2021, Frontiers in Immunology.

[5]  V. Navarro,et al.  Nutritional Imbalances in Adult Celiac Patients Following a Gluten-Free Diet , 2021, Nutrients.

[6]  P. Cras,et al.  Safety and immunological proof-of-concept following treatment with tolerance-inducing cell products in patients with autoimmune diseases or receiving organ transplantation: A systematic review and meta-analysis of clinical trials. , 2021, Autoimmunity reviews.

[7]  Katherine R. Sebastian,et al.  High-throughput and high-dimensional single-cell analysis of antigen-specific CD8+ T cells , 2021, Nature Immunology.

[8]  L. Passeri,et al.  Regulatory Cell Therapy in Organ Transplantation: Achievements and Open Questions , 2021, Frontiers in Immunology.

[9]  C. Speake,et al.  The many faces of islet antigen‐specific CD8 T cells: clues to clinical outcome in type 1 diabetes , 2021, Immunology and cell biology.

[10]  E. Martínez-Cáceres,et al.  Vitamin D3-Induced Tolerogenic Dendritic Cells Modulate the Transcriptomic Profile of T CD4+ Cells Towards a Functional Hyporesponsiveness , 2021, Frontiers in Immunology.

[11]  A. Kajaste-Rudnitski,et al.  Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer , 2020, Frontiers in Immunology.

[12]  A. Folgori,et al.  MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans , 2020, Science Translational Medicine.

[13]  E. D. de Koning,et al.  Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide-for type 1 diabetes. , 2020, The lancet. Diabetes & endocrinology.

[14]  Shannon K. Boi,et al.  Beta cell-specific CD8+ T cells maintain stem-cell memory-associated epigenetic programs during type 1 diabetes , 2020, Nature Immunology.

[15]  Ami A. Shah,et al.  The relationships between cancer and autoimmune rheumatic diseases. , 2020, Best practice & research. Clinical rheumatology.

[16]  Scott R. Presnell,et al.  Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression. , 2019, The Journal of clinical investigation.

[17]  James A. Hutchinson,et al.  Human Tolerogenic Dendritic Cells Regulate Immune Responses through Lactate Synthesis. , 2019, Cell metabolism.

[18]  P. Linsley,et al.  Enforcing the checkpoints: harnessing T-cell exhaustion for therapy of T1D , 2019, Current opinion in endocrinology, diabetes, and obesity.

[19]  Yan Ding,et al.  The Emerging Epigenetic Role of CD8+T Cells in Autoimmune Diseases: A Systematic Review , 2019, Front. Immunol..

[20]  M. Juan,et al.  Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial , 2019, Proceedings of the National Academy of Sciences.

[21]  M. Roncarolo,et al.  Coexpression of CD163 and CD141 identifies human circulating IL-10-producing dendritic cells (DC-10) , 2019, Cellular & Molecular Immunology.

[22]  G. Kvalheim,et al.  Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity , 2019, Oncoimmunology.

[23]  R. Flavell,et al.  Intestinal IFN‐&ggr;–producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL‐10 in the inflamed guts of patients with inflammatory bowel disease , 2018, The Journal of allergy and clinical immunology.

[24]  Francis J. Huber,et al.  IL-10 Receptor Signaling Is Essential for TR1 Cell Function In Vivo , 2017, The Journal of Immunology.

[25]  Hanspeter Herzel,et al.  Adequate immune response ensured by binary IL-2 and graded CD25 expression in a murine transfer model , 2016, eLife.

[26]  James A. Eddy,et al.  Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes , 2016, Science Immunology.

[27]  Roland Eils,et al.  Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..

[28]  Z. Berneman,et al.  Cryopreserved vitamin D3-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients , 2016, Journal of Neuroinflammation.

[29]  J. Isaacs,et al.  Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis , 2016, Annals of the rheumatic diseases.

[30]  D. Harlan,et al.  Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion , 2016, Science.

[31]  Scott J. Tebbutt,et al.  A Regulatory T-Cell Gene Signature Is a Specific and Sensitive Biomarker to Identify Children With New-Onset Type 1 Diabetes , 2016, Diabetes.

[32]  I. Ordás,et al.  Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for Refractory Crohn's Disease: A Phase I Study. , 2015, Journal of Crohn's & colitis.

[33]  Ahmed M. Mehdi,et al.  Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype–positive rheumatoid arthritis patients , 2015, Science Translational Medicine.

[34]  E. Martínez-Cáceres,et al.  Beneficial Effect of Tolerogenic Dendritic Cells Pulsed with MOG Autoantigen in Experimental Autoimmune Encephalomyelitis , 2015, CNS neuroscience & therapeutics.

[35]  P. Carmeliet,et al.  Vitamin D3 Induces Tolerance in Human Dendritic Cells by Activation of Intracellular Metabolic Pathways. , 2015, Cell reports.

[36]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[37]  G. Nepom,et al.  Restoring the balance: immunotherapeutic combinations for autoimmune disease , 2014, Disease Models & Mechanisms.

[38]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[39]  Clelia Di Serio,et al.  Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells , 2013, Nature Medicine.

[40]  K. Steinbrink,et al.  Costimulatory Molecules on Immunogenic Versus Tolerogenic Human Dendritic Cells , 2013, Front. Immunol..

[41]  M. Roncarolo,et al.  Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  F. Nestle,et al.  Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation , 2012, The Journal of experimental medicine.

[43]  D. Finegold,et al.  Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients , 2011, Diabetes Care.

[44]  R. Bronson,et al.  Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope , 2011, The Journal of experimental medicine.

[45]  E. Hauben,et al.  Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. , 2010, Blood.

[46]  Glinda S Cooper,et al.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. , 2009, Journal of autoimmunity.

[47]  B. Chain,et al.  Lentiviral vectors transduce proliferating dendritic cell precursors leading to persistent antigen presentation and immunization. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[48]  M. V. von Herrath,et al.  Mouse Models for Type 1 Diabetes. , 2009, Drug discovery today. Disease models.

[49]  J. Sidney,et al.  Intestinal T Cell Responses to Gluten Peptides Are Largely Heterogeneous: Implications for a Peptide-Based Therapy in Celiac Disease1 , 2009, The Journal of Immunology.

[50]  D. Voehringer,et al.  Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity , 2009, The Journal of experimental medicine.

[51]  P. van Endert,et al.  The Frequency and Immunodominance of Islet-Specific CD8+ T-cell Responses Change after Type 1 Diabetes Diagnosis and Treatment , 2008, Diabetes.

[52]  P. Halloran,et al.  The Transcriptome of Human Cytotoxic T Cells: Similarities and Disparities Among Allostimulated CD4+ CTL, CD8+ CTL and NK cells , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[53]  P. Greenberg,et al.  Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. , 2007, Blood.

[54]  B. Chain,et al.  Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[55]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Zhiliang Wang,et al.  Rapamycin‐Treated, Alloantigen‐Pulsed Host Dendritic Cells Induce Ag‐Specific T Cell Regulation and Prolong Graft Survival , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[57]  L. Naldini,et al.  Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters , 2005, Nature Biotechnology.

[58]  M. Cotten,et al.  MHC class II presentation of endogenously expressed antigens by transfected dendritic cells , 2001, Gene Therapy.

[59]  L. Ailles,et al.  Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences , 2000, Nature Genetics.

[60]  K. Schooley,et al.  Human Dendritic Cells Mediate Cellular Apoptosis via Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) , 1999, The Journal of experimental medicine.

[61]  P. Allavena,et al.  Glucocorticoids affect human dendritic cell differentiation and maturation. , 1999, Journal of immunology.

[62]  M. Colonna,et al.  A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells , 1997, The Journal of experimental medicine.

[63]  A. Enk,et al.  Induction of tolerance by IL-10-treated dendritic cells. , 1997, Journal of immunology.

[64]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[65]  S. Karlsson,et al.  A bicistronic therapeutic retroviral vector enables sorting of transduced CD34+ cells and corrects the enzyme deficiency in cells from Gaucher patients. , 1996, Blood.

[66]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[67]  Mark S. Anderson,et al.  The NOD mouse: a model of immune dysregulation. , 2005, Annual review of immunology.